Member Info for Livedataaccount

Thus far they signed a deal with bioserv. By the looks of it an Internet reseller of medical products.

I applaud everyone's efforts in contacting mps about the government ordering chinese tests. At what point should people start asking Avacta serious questions about why there has no communication about serious LFT sales?

The company have been very vocal about significant manufacturing capacity and selling all they can manufacture in multiple presentations over the previous year. Most recently stating about over 20 ongoing discussions with potential buyers.

Added earlier today. Its very positive

https://bioservuk.com/?s=AvactA&post_type=product

Code junkie. That has been my thinking too. Deliveries of the LFT starting next week may help shore up the share price.

You make am interesting point. Something I've been pondering. If you were to remove the covid element and assuming first dose of ava6000 happens in the next couple couple of weeks.

How would avacta be valued?

Phlobacht. The issue is investors are expecting that holy grail RNS because that's what's been pumped up for the last 16 months or so. 'We will sell all we can make, linited by manufacturing, projections of 5 -30 million tests a month, talks with Asian manufacturers to produce a million tests a day if needed. But..... never has it been rrally spelled out this could take months to happen, might not be needed, etc

I think most invested on the story that Avacta will be at least part of the UK government testing regime. Moonshot etc. That hasn't materialised yet and with loxkdown measures going will testing decrease?

Avacta then stated they are in discussions with 27 countries or whatever. Its taken an absolute age to get the test to market and let's face it majority of folk, naively or not expected blockbuster sales. This hasn't materialised. Not saying it won't and wouldn't surprise if avacta pull off a few big deals but patience is obviously waning.

It's menial in the scheme of things but in recent presentation mid july was scheduled for fist does. Then yesterday, shortly, in the coming weeks.
All creates confusion.

Stick to an rns.

Ava6000

Avacta don't help themselves at all and don't learn.

Yesterday's video for first dosing of Avacta has the same old phrases. Coming shortly. In the coming weeks.

Why not just release an RNS when it's started then release a video.

Last question in the 22nd April video presentation.

Neil Bell confirms Avacta are doing clinical trials at Royal Marsden for AVA6000 cancel trials.

Expects the first patient dosing by mid July.

Which presentation was it?

Unless the Portuguese health minister is a fan of perusing the bioserv website for lft's, id say not very!

https://www.nih.gov/news-events/news-releases/nih-funded-screening-study-builds-case-frequent-covid-19-antigen-testing

With bioserv expecting their first shipment of lfts from Avacta on the 15th hoping that any larger orders that Avacta have received will be announced then too. Avacta mentioned that they are dealing with the bigger orders themselves.

Mid this month is also when they expect to dose the first humans for the ava600 human cancer trials so could be an interesting couple of weeks

Why don't you call them back?

Ray, I should think Avacta are more excited about the Ava6000 human cancer trials due to start I'm the coming days.

Why don't Avacta name the other tests?
They do it on TV all the time.

This News release should be sent to every headteacher in the UK.